[HTML][HTML] Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine
…, HE Janes, MC Nason, JA Green… - … England Journal of …, 2021 - Mass Medical Soc
Background The safety and efficacy of the AZD1222 (ChAdOx1 nCoV-19) vaccine in a large,
diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (…
diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (…
[HTML][HTML] Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts
Severe acute respiratory syndrome (SARS) is an emerging viral infectious disease. One of
the largest outbreaks of SARS to date began in Singapore in March 2003. We describe the …
the largest outbreaks of SARS to date began in Singapore in March 2003. We describe the …
Lutein and zeaxanthin in eye and skin health
RL Roberts, J Green, B Lewis - Clinics in Dermatology, 2009 - Elsevier
Less than 20 of the hundreds of carotenoids found in nature are found in the human body.
These carotenoids are present in the body because they come from the foods or dietary …
These carotenoids are present in the body because they come from the foods or dietary …
[HTML][HTML] Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose …
…, D Wilkins, EJ Kelly, T Villafana, JA Green… - …, 2022 - thelancet.com
Background Intranasal vaccination may induce protective local and systemic immune responses
against respiratory pathogens. A number of intranasal SARS-CoV-2 vaccine candidates …
against respiratory pathogens. A number of intranasal SARS-CoV-2 vaccine candidates …
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b …
…, C Ugwuegbulam, JP Kleim, N Carter, JA Green… - The Lancet, 2014 - thelancet.com
Background Clinical effectiveness of previous regimens to treat Plasmodium vivax infection
have been hampered by compliance. We aimed to assess the dose–response, safety, and …
have been hampered by compliance. We aimed to assess the dose–response, safety, and …
[HTML][HTML] Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
…, JJ Breton, CO Ugwuegbulam, JA Green… - … England Journal of …, 2019 - Mass Medical Soc
Background Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites,
but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a …
but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a …
[HTML][HTML] Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
…, VM Wilches, JJ Breton, JA Green - … England Journal of …, 2019 - Mass Medical Soc
Background Tafenoquine, a single-dose therapy for Plasmodium vivax malaria, has been
associated with relapse prevention through the clearance of P. vivax parasitemia and …
associated with relapse prevention through the clearance of P. vivax parasitemia and …
[HTML][HTML] G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
…, Q Cheng, J Culpepper, C Eziefula, M Fukuda, J Green… - 2013 - Springer
Malaria elimination will be possible only with serious attempts to address asymptomatic
infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently …
infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently …
Hypoxia and tissue destruction in pulmonary TB
Background It is unknown whether lesions in human TB are hypoxic or whether this influences
disease pathology. Human TB is characterised by extensive lung destruction driven by …
disease pathology. Human TB is characterised by extensive lung destruction driven by …
Pseudoporphyria
JJ Green, SM Manders - Journal of the American Academy of Dermatology, 2001 - Elsevier
Pseudoporphyria is the term used to describe a photodistributed bullous disorder with clinical
and histologic features of porphyria cutanea tarda, but without accompanying biochemical …
and histologic features of porphyria cutanea tarda, but without accompanying biochemical …